Chris Wagner

Chris Wagner

Chief Executive Officer at
Immunoflex Therapeutics, Inc.
57 year
Health Technology
Consumer Services
Industrial Services

Profile

Chris Wagner was the founder of Canexia Health, Inc. (Canada), founded in 2012, where the title held was Chief Executive Officer.
Mr. Wagner is also the founder of Aspreva Pharmaceuticals Corp.,Immunoflex Therapeutics, Inc...
Mr. Wagner currently holds the position of Director at Contextual Health since 2019.
Mr. Wagner also serves as Area Manager-New Mexico at Meridian Engineering Co. Former positions include President & Chief Executive Officer at Sirius Genomics, Inc., Director at Emerald Health Therapeutics, Inc. from 2018 to 2019, Independent Director at Filament Health Corp.
from 2021 to 2024, and Principal at Eli Lilly & Co. Education includes undergraduate studies at the University of British Columbia.

Chris Wagner active positions

CompaniesPositionStart
Director/Board Member 2019-04-30
Corporate Officer/Principal -
Immunoflex Therapeutics, Inc.
Chief Executive Officer -

Former positions of Chris Wagner

CompaniesPositionEnd
FILAMENT HEALTH CORP. Director/Board Member 2024-03-31
EMERALD HEALTH THERAPEUTICS Chief Executive Officer 2018-11-27
Chief Executive Officer -
Founder -
ELI LILLY AND COMPANY Corporate Officer/Principal -
See the detail of Chris Wagner's experience

Training of Chris Wagner

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

8

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies10

Health Technology

Health Technology

Consumer Services

Health Technology

Industrial Services

Process Industries

Health Technology

Health Technology

Immunoflex Therapeutics, Inc.

Health Services